Therefore, in the present study, we analyzed the expression of PAQR3 and its clinical value in NSCLC, and explored its function in the progression of NSCLC to provide a new target for molecular diagnosis and treatment of lung cancer. This evidence concerns the gene PAQR3 and non-small cell lung carcinoma.